| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An illustrated review of bleeding assessment tools and common coagulation tests
|
Elbaz, Carolyne
|
|
|
4 |
5 |
p. 761-773
|
artikel
|
| 2 |
Anticoagulation after intracranial hemorrhage in brain tumors: Risk of recurrent hemorrhage and venous thromboembolism
|
Carney, Brian J.
|
|
|
4 |
5 |
p. 860-865
|
artikel
|
| 3 |
Anticoagulation, immortality, and observations of COVID‐19
|
Maley, Jason H.
|
|
|
4 |
5 |
p. 674-676
|
artikel
|
| 4 |
Antiviral anticoagulation
|
Pryzdial, Edward L.G.
|
|
|
4 |
5 |
p. 774-788
|
artikel
|
| 5 |
A proposal for staging COVID‐19 coagulopathy
|
Thachil, Jecko
|
|
|
4 |
5 |
p. 731-736
|
artikel
|
| 6 |
A risk score for prediction of venous thromboembolism in gynecologic cancer: The Thrombogyn score
|
Norris, Lucy A.
|
|
|
4 |
5 |
p. 848-859
|
artikel
|
| 7 |
Bleeding is increased in amyloid precursor protein knockout mouse
|
Mazinani, Nima
|
|
|
4 |
5 |
p. 823-828
|
artikel
|
| 8 |
Bleeding risks for uncharacterized platelet function disorders
|
Brunet, Justin
|
|
|
4 |
5 |
p. 799-806
|
artikel
|
| 9 |
Blood and Bone: The quarantine chronicles
|
Taylor, Kirk A.
|
|
|
4 |
5 |
p. 727-730
|
artikel
|
| 10 |
Determination of von Willebrand factor level in patient with sickle cell diseasein vaso‐occlusive crisis
|
Akaba, Kingsley
|
|
|
4 |
5 |
p. 902-905
|
artikel
|
| 11 |
Development of inhibitors in hemophilia A: An illustrated review
|
Jardim, Letícia Lemos
|
|
|
4 |
5 |
p. 752-760
|
artikel
|
| 12 |
Effect of pH on thrombin activity measured by calibrated automated thrombinography
|
Jackson, Joseph W.
|
|
|
4 |
5 |
p. 944-945
|
artikel
|
| 13 |
Gender gap in women authors is not worse during COVID‐19 pandemic: Results from Research and Practice in Thrombosis and Haemostasis
|
Cushman, Mary
|
|
|
4 |
5 |
p. 672-673
|
artikel
|
| 14 |
Generation and validation of small ADAMTS13 fragments for epitope mapping of anti‐ADAMTS13 autoantibodies in immune‐mediated thrombotic thrombocytopenic purpura
|
Kangro, Kadri
|
|
|
4 |
5 |
p. 918-930
|
artikel
|
| 15 |
Heparin‐induced thrombocytopenia with thrombosis in COVID‐19 adult respiratory distress syndrome
|
Riker, Richard R.
|
|
|
4 |
5 |
p. 936-941
|
artikel
|
| 16 |
Illustrated State‐of‐the‐Art Capsules of the ISTH 2020 Congress
|
Ariens, Robert
|
|
|
4 |
5 |
p. 680-713
|
artikel
|
| 17 |
ISSUE INFORMATION
|
|
|
|
4 |
5 |
p. 667-671
|
artikel
|
| 18 |
Liver fibrosis is driven by protease‐activated receptor‐1 expressed by hepatic stellate cells in experimental chronic liver injury
|
Poole, Lauren G.
|
|
|
4 |
5 |
p. 906-917
|
artikel
|
| 19 |
Measuring beta‐galactose exposure on platelets: Standardization and healthy reference values
|
Lasne, Dominique
|
|
|
4 |
5 |
p. 813-822
|
artikel
|
| 20 |
N‐Methyl‐3,4‐methylendioxymethamphetamine (MDMA)‐related coagulopathy and rhabdomyolysis: A case series and literature review
|
Doyle, Andrew J.
|
|
|
4 |
5 |
p. 829-834
|
artikel
|
| 21 |
N‐Terminal pro‐B‐type natriuretic peptide and stroke risk across a spectrum of cerebrovascular disease: The REasons for Geographic and Racial Differences in Stroke cohort
|
Judd, Suzanne E.
|
|
|
4 |
5 |
p. 893-901
|
artikel
|
| 22 |
Potential role of platelets in COVID‐19: Implications for thrombosis
|
Koupenova, Milka
|
|
|
4 |
5 |
p. 737-740
|
artikel
|
| 23 |
Predicting postdischarge hospital‐associated venous thromboembolism among medical patients using a validated mortality risk score derived from common biomarkers
|
Snyder, Lindsey
|
|
|
4 |
5 |
p. 872-878
|
artikel
|
| 24 |
Protease: Serpin complexes to assess contact system and intrinsic pathway activation
|
Henderson, Michael W.
|
|
|
4 |
5 |
p. 789-798
|
artikel
|
| 25 |
Prothrombin complex concentrates for DOAC‐associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact?
|
Shaw, Joseph R.
|
|
|
4 |
5 |
p. 677-679
|
artikel
|
| 26 |
Pulmonary embolism during the COVID‐19 pandemic: Decline in diagnostic procedures and incidence at a university hospital
|
Nopp, Stephan
|
|
|
4 |
5 |
p. 835-841
|
artikel
|
| 27 |
Pulmonary embolism in acute lymphoblastic leukemia — An observational study of 1685 patients treated according to the NOPHO ALL2008 protocol
|
Tuckuviene, Ruta
|
|
|
4 |
5 |
p. 866-871
|
artikel
|
| 28 |
Serum complement levels in immune thrombocytopenia: Characterization and relation to clinical features
|
Cheloff, Abraham Z.
|
|
|
4 |
5 |
p. 807-812
|
artikel
|
| 29 |
Sex differences in flow cytometry–based platelet reactivity in stable outpatients suspected of myocardial ischemia
|
Waissi, Farahnaz
|
|
|
4 |
5 |
p. 879-885
|
artikel
|
| 30 |
Staying updated on COVID‐19: Social media to amplify science in thrombosis and hemostasis
|
Makris, Mike
|
|
|
4 |
5 |
p. 722-726
|
artikel
|
| 31 |
The Edoxaban Hokusai VTE PEDIATRICS Study: An open‐label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic disease
|
van Ommen, Cornelia Heleen
|
|
|
4 |
5 |
p. 886-892
|
artikel
|
| 32 |
The odds and implications of coinheritance of hemophilia A and B
|
Karch, Corinne
|
|
|
4 |
5 |
p. 931-935
|
artikel
|
| 33 |
The underrecognized prothrombotic vascular disease of COVID‐19
|
Cohoon, Kevin P.
|
|
|
4 |
5 |
p. 942-943
|
artikel
|
| 34 |
Thrombosis and coagulopathy in COVID‐19: An illustrated review
|
Levi, Marcel
|
|
|
4 |
5 |
p. 744-751
|
artikel
|
| 35 |
Thrombosis and thromboembolism related to COVID‐19: A clarion call for obtaining solid estimates from large‐scale multicenter data
|
Barco, Stefano
|
|
|
4 |
5 |
p. 741-743
|
artikel
|
| 36 |
Venous thromboembolism in critically Ill patients with COVID‐19: Results of a screening study for deep vein thrombosis
|
Longchamp, Alban
|
|
|
4 |
5 |
p. 842-847
|
artikel
|
| 37 |
Venous thromboembolism research priorities: A scientific statement from the American Heart Association and the International Society on Thrombosis and Haemostasis
|
Cushman, Mary
|
|
|
4 |
5 |
p. 714-721
|
artikel
|
Tijdschrift beschrijving